OBJECTIVE—Diet composition alters the metabolic states of adipocytes and hepatocytes in diabetes. The effects of dipeptidyl peptidase-4 (DPP-4) inhibition on adipose tissue inflammation and fatty liver have been obscure. We investigated the extrap-ancreatic effects of DPP-4 inhibition on visceral fat and the liver. RESEARCH DESIGN AND METHODS—We investigated diet-induced metabolic changes in b-cell–specific glucokinase hap-loinsufficient (Gck+/2) diabetic mice. We challenged animals with a diet containing a combination of sucrose and oleic acid (SO) or sucrose and linoleic acid (SL). Next, we assessed the effects of a DPP-4 inhibitor, des-fluoro-sitagliptin, on adipose tissue inflam-mation and hepatic steatosis. RESULTS—The epididymal fat w...
Background—Dipeptidyl-peptidase 4 (DPP-4) inhibitors are increasingly used to accomplish glycemic ta...
Obesity and type 2 diabetes are the most common metabolic diseases globally. They are associated wit...
OBJECTIVE-Comprehensive proteomic profiling of the human adipocyte secretome identified dipeptidyl p...
OBJECTIVE—Diet composition alters the metabolic states of adipocytes and hepatocytes in diabetes. Th...
OBJECTIVE: Increased hepatic expression of dipeptidyl peptidase 4 (DPP4) is associated with non-alco...
Objective: Dipeptidyl peptidase (DPP)-4 is responsible for the degradation of several peptides that ...
Dipeptidyl peptidase 4 (DPP-4) inhibitors are widely used anti-hyperglycemic agents for type 2 diabe...
Dipeptidyl peptidase 4 (DPP-4) inhibitors are widely used anti-hyperglycemic agents for type 2 diabe...
Dipeptidyl peptidase (DPP)-4 is responsible for the degradation of several peptides that contain an ...
Additional file 3: Figure S2. Liver and epididymal fat weights in db/+ mice and db/db mice. The expe...
Obesity-induced metabolic disease involves functional integration among several organs via circulati...
Adipose tissue inflammation is a major cause of the pathogenesis of obesity and comorbidities. To st...
Dipeptidyl peptidase (DPP)-4 is responsible for the degradation of several peptides that contain an ...
Objective Interventions for hyperinsulinemia (HINS), an early indicator of type 2 diabetes mellitus ...
OBJECTIVE: Sitagliptin and other dipeptidyl peptidase (DPP)-4 inhibitors/gliptins are antidiabetic d...
Background—Dipeptidyl-peptidase 4 (DPP-4) inhibitors are increasingly used to accomplish glycemic ta...
Obesity and type 2 diabetes are the most common metabolic diseases globally. They are associated wit...
OBJECTIVE-Comprehensive proteomic profiling of the human adipocyte secretome identified dipeptidyl p...
OBJECTIVE—Diet composition alters the metabolic states of adipocytes and hepatocytes in diabetes. Th...
OBJECTIVE: Increased hepatic expression of dipeptidyl peptidase 4 (DPP4) is associated with non-alco...
Objective: Dipeptidyl peptidase (DPP)-4 is responsible for the degradation of several peptides that ...
Dipeptidyl peptidase 4 (DPP-4) inhibitors are widely used anti-hyperglycemic agents for type 2 diabe...
Dipeptidyl peptidase 4 (DPP-4) inhibitors are widely used anti-hyperglycemic agents for type 2 diabe...
Dipeptidyl peptidase (DPP)-4 is responsible for the degradation of several peptides that contain an ...
Additional file 3: Figure S2. Liver and epididymal fat weights in db/+ mice and db/db mice. The expe...
Obesity-induced metabolic disease involves functional integration among several organs via circulati...
Adipose tissue inflammation is a major cause of the pathogenesis of obesity and comorbidities. To st...
Dipeptidyl peptidase (DPP)-4 is responsible for the degradation of several peptides that contain an ...
Objective Interventions for hyperinsulinemia (HINS), an early indicator of type 2 diabetes mellitus ...
OBJECTIVE: Sitagliptin and other dipeptidyl peptidase (DPP)-4 inhibitors/gliptins are antidiabetic d...
Background—Dipeptidyl-peptidase 4 (DPP-4) inhibitors are increasingly used to accomplish glycemic ta...
Obesity and type 2 diabetes are the most common metabolic diseases globally. They are associated wit...
OBJECTIVE-Comprehensive proteomic profiling of the human adipocyte secretome identified dipeptidyl p...